Schizoaffective Disorders Completed Phase 2 Trials for Ziprasidone (DB00246)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00650611A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersTreatment